These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28483293)

  • 1. Population Pharmacokinetics of Valproic Acid in Patients with Mania: Implication for Individualized Dosing Regimens.
    Methaneethorn J
    Clin Ther; 2017 Jun; 39(6):1171-1181. PubMed ID: 28483293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of valproic acid in adult Chinese patients with bipolar disorder.
    Zang YN; Guo W; Niu MX; Bao S; Wang Q; Wang Y; Dong F; Li AN; Ruan CJ
    Eur J Clin Pharmacol; 2022 Mar; 78(3):405-418. PubMed ID: 34854947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
    Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
    Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive ability of published population pharmacokinetic models of valproic acid in Thai manic patients.
    Methaneethorn J; Leelakanok N
    J Clin Pharm Ther; 2021 Feb; 46(1):198-207. PubMed ID: 32986889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External evaluation of a published population pharmacokinetic model of valproic acid in Thai manic patients.
    Methaneethorn J; Lohitnavy M
    Eur J Hosp Pharm; 2020 May; 27(3):168-172. PubMed ID: 32419938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?
    Haymond J; Ensom MH
    Ther Drug Monit; 2010 Feb; 32(1):19-29. PubMed ID: 19901867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium in Paediatric Patients with Bipolar Disorder: Implications for Selection of Dosage Regimens via Population Pharmacokinetics/Pharmacodynamics.
    Landersdorfer CB; Findling RL; Frazier JA; Kafantaris V; Kirkpatrick CM
    Clin Pharmacokinet; 2017 Jan; 56(1):77-90. PubMed ID: 27393139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of carbamazepine-induced changes in valproic acid relative clearance in man by simple pharmacokinetic screening.
    Yukawa E; Honda T; Ohdo S; Higuchi S; Aoyama T
    J Pharm Pharmacol; 1997 Aug; 49(8):751-6. PubMed ID: 9379350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of apparent clearance of valproic acid in adult Saudi patients.
    Alqahtani S; Alandas N; Alsultan A
    Int J Clin Pharm; 2019 Aug; 41(4):1056-1061. PubMed ID: 31222537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of valproic acid in patients with bipolar disorder.
    Vasudev K; Das S; Goswami U; Tayal G
    J Psychopharmacol; 2001 Sep; 15(3):187-90. PubMed ID: 11565626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of unbound valproic acid in pediatric epilepsy patients in China: a protein binding model.
    Gu X; Zhu M; Sheng C; Yu S; Peng Q; Ma M; Hu Y; Li Z; Jiao Z; Zhou B
    Eur J Clin Pharmacol; 2021 Jul; 77(7):999-1009. PubMed ID: 33423079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
    Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN
    Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis.
    Bae EK; Lee J; Shin JW; Moon J; Lee KJ; Shin YW; Kim TJ; Shin D; Jang IJ; Lee SK
    Seizure; 2016 Apr; 37():8-12. PubMed ID: 26908152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose intravenous valproate in acute mania.
    Phrolov K; Applebaum J; Levine J; Miodovnick H; Belmaker RH
    J Clin Psychiatry; 2004 Jan; 65(1):68-70. PubMed ID: 14744171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of intravenous valproate in acute mania.
    Norton JW
    Gen Hosp Psychiatry; 2000; 22(5):389-91. PubMed ID: 11203036
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of valproate plasma concentrations and dose in bipolar affective disorder.
    Perry PJ; Bever-Stille KA; Arndt S; Gundersen S
    J Clin Psychopharmacol; 2000 Apr; 20(2):277-9. PubMed ID: 10770477
    [No Abstract]   [Full Text] [Related]  

  • 17. Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years.
    Schoemaker R; Wade JR; Stockis A
    Eur J Clin Pharmacol; 2017 Jun; 73(6):727-733. PubMed ID: 28280887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of valproic acid concentrations in elderly nursing home residents.
    Birnbaum AK; Ahn JE; Brundage RC; Hardie NA; Conway JM; Leppik IE
    Ther Drug Monit; 2007 Oct; 29(5):571-5. PubMed ID: 17898646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of valproate in Mexican children with epilepsy.
    Correa T; Rodríguez I; Romano S
    Biopharm Drug Dispos; 2008 Dec; 29(9):511-20. PubMed ID: 19067436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
    Jankovic SM; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.